相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
Yvette Drew et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The IKK complex contributes to the induction of autophagy
Alfredo Criollo et al.
EMBO JOURNAL (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines
T. Zaremba et al.
BRITISH JOURNAL OF CANCER (2009)
Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
Rachel A. Daniel et al.
CLINICAL CANCER RESEARCH (2009)
PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications
Yvette Drew et al.
DRUG RESISTANCE UPDATES (2009)
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
Saman Hewamana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Nuclear Poly(ADP-Ribose)-Dependent Signalosome Confers DNA Damage-Induced IκB Kinase Activation
Michael Stilmann et al.
MOLECULAR CELL (2009)
Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
S. J. Veuger et al.
ONCOGENE (2009)
The NF-κB-independent functions of IKK subunits in immunity and cancer
Alain Chariot
TRENDS IN CELL BIOLOGY (2009)
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana et al.
BLOOD (2008)
The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine
Saman Hewamana et al.
CLINICAL CANCER RESEARCH (2008)
Phase I Study of the Poly (ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2008)
Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference
Darjus Tschaharganeh et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis
David Martin-Oliva et al.
CANCER RESEARCH (2006)
Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
ER Plummer et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of poly(ADP-ribose) metabolism by poly(ADP-ribose) glycohydrolase: where and when?
ME Bonicalzi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death
UM Kauppinen et al.
JOURNAL OF IMMUNOLOGY (2005)
The NF-kappa B/I kappa B signaling system: A molecular target in breast cancer therapy
JT Wu et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
HM Wang et al.
LABORATORY INVESTIGATION (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
NF-kappa B/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors
MC Turco et al.
LEUKEMIA (2004)
Noise amidst the silence: off-target effects of siRNAs?
AL Jackson et al.
TRENDS IN GENETICS (2004)
Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation
T Criswell et al.
ONCOGENE (2003)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
The sequence-specific DNA binding of NF-κB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1
WJ Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
NF-κB signaling pathway as a target for human tumor radiosensitization
M Jung et al.
SEMINARS IN RADIATION ONCOLOGY (2001)
Enhancement of radiosensitivity by proteasome inhibition:: Implications for a role of NF-κB
SM Russo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
The world according to PARP
S Smith
TRENDS IN BIOCHEMICAL SCIENCES (2001)
分享论文
